Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:negative regulation of type IV hypersensitivity
go back to main search page
Accession:GO:0001808 term browser browse the term
Definition:Any process that stops, prevents, or reduces the rate of type IV hypersensitivity, a type of inflammatory response.
Synonyms:exact_synonym: down regulation of type IV hypersensitivity;   downregulation of type IV hypersensitivity
 narrow_synonym: inhibition of type IV hypersensitivity


show annotations for term's descendants       view all columns           Sort by:
 
negative regulation of type IV hypersensitivity term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Il20rb interleukin 20 receptor subunit beta JBrowse link 8 108,745,906 108,778,561 RGD:1624291
G Spn sialophorin JBrowse link 1 198,572,999 198,585,664 RGD:1624291

Term paths to the root
Path 1
Term Annotations click to browse term
  biological_process 19439
    immune system process 2631
      immune effector process 849
        leukocyte mediated immunity 492
          lymphocyte mediated immunity 395
            T cell mediated immunity 134
              type IV hypersensitivity 6
                negative regulation of type IV hypersensitivity 2
Path 2
Term Annotations click to browse term
  biological_process 19439
    biological regulation 13446
      regulation of biological process 12748
        regulation of response to stimulus 3996
          regulation of response to stress 1366
            regulation of defense response 609
              regulation of inflammatory response 362
                regulation of acute inflammatory response 54
                  regulation of acute inflammatory response to antigenic stimulus 20
                    regulation of hypersensitivity 14
                      regulation of type IV hypersensitivity 4
                        negative regulation of type IV hypersensitivity 2
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.